SG Americas Securities LLC trimmed its position in shares of Colgate-Palmolive (NYSE:CL) by 36.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,319 shares of the company’s stock after selling 25,108 shares during the period. SG Americas Securities LLC’s holdings in Colgate-Palmolive were worth $2,872,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Rainier Group Investment Advisory LLC acquired a new position in Colgate-Palmolive during the first quarter worth $107,000. Quadrant Capital Group LLC increased its position in Colgate-Palmolive by 142.4% during the first quarter. Quadrant Capital Group LLC now owns 1,602 shares of the company’s stock worth $108,000 after buying an additional 941 shares during the last quarter. Centerpoint Advisors LLC acquired a new position in Colgate-Palmolive during the first quarter worth $112,000. Princeton Capital Management LLC acquired a new position in Colgate-Palmolive during the first quarter worth $117,000. Finally, Kaizen Advisory LLC increased its position in Colgate-Palmolive by 134.8% during the second quarter. Kaizen Advisory LLC now owns 1,979 shares of the company’s stock worth $128,000 after buying an additional 1,136 shares during the last quarter. Institutional investors and hedge funds own 74.72% of the company’s stock.

In related news, VP Justin Skala sold 90,069 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 2nd. The stock was sold at an average price of $66.36, for a total transaction of $5,976,978.84. Following the sale, the vice president now directly owns 65,061 shares of the company’s stock, valued at $4,317,447.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Mukul Deoras sold 11,334 shares of Colgate-Palmolive stock in a transaction dated Monday, August 13th. The stock was sold at an average price of $65.10, for a total value of $737,843.40. Following the sale, the insider now directly owns 32,625 shares in the company, valued at $2,123,887.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 433,302 shares of company stock worth $28,518,498. 1.02% of the stock is owned by company insiders.

Several research firms have commented on CL. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Wells Fargo & Co reissued a “hold” rating and set a $64.00 target price on shares of Colgate-Palmolive in a research report on Friday, July 27th. Macquarie downgraded shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $74.00 to $65.00 in a research report on Monday, July 30th. Morgan Stanley downgraded Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a research report on Monday, April 30th. Finally, Barclays set a $64.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research report on Monday, July 30th. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $72.14.

Shares of NYSE:CL opened at $66.88 on Friday. The stock has a market capitalization of $58.13 billion, a PE ratio of 22.41, a price-to-earnings-growth ratio of 3.00 and a beta of 0.75. Colgate-Palmolive has a 52-week low of $61.28 and a 52-week high of $77.91. The company has a debt-to-equity ratio of -34.49, a quick ratio of 0.74 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.77. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.91 billion. Colgate-Palmolive had a return on equity of 2,494.79% and a net margin of 13.97%. The firm’s revenue was up 1.6% compared to the same quarter last year. During the same period last year, the business posted $0.72 earnings per share. sell-side analysts predict that Colgate-Palmolive will post 3.02 earnings per share for the current year.

Colgate-Palmolive announced that its board has authorized a share repurchase program on Monday, June 18th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 15th. Investors of record on Wednesday, July 18th were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend was Tuesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: Penny Stocks

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.